![Lantheus Holdings, Inc. logo](/logos/LNTH.webp)
Lantheus Holdings, Inc.
NASDAQ:LNTH
Overview | Financials
Company Name | Lantheus Holdings, Inc. |
Symbol | LNTH |
Currency | USD |
Price | 101.98 |
Market Cap | 7,080,532,588 |
Dividend Yield | 0% |
52-week-range | 50.2 - 126.89 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Mary Anne Heino |
Website | https://www.lantheus.com |
An error occurred while fetching data.
About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD